Health TrialsbyHealthPanel

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in Portugal

The purpose of this study is to understand how the participants with high-risk non-muscle invasive bladder cancer are diagnosed, treated, and cared for in regular clinical practice in Portugal. HR-NMIBC is an early-stage bladder cancer that is limited to the inner lining of bladder but has a considerable high chance of cancer coming back or worsening.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen-Cilag Farmaceutica Ltda.Updated: Aug 28, 2026Locations: 1
Eligibility criteria

Bladder cancer diagnosis between January 1, 2016 and December 31, 2020 [+2]

Tumor stage at diagnosis classified as TaG1-2, T2-T4, N1-3, or M1 [+2]

Read more
Status: Not yet recruiting

A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)

This study aims to better understand people who have advanced or metastatic non-small cell lung cancer (NSCLC) with an EGFR mutation. NSCLC is an advanced stage cancer of the lung, occurring due to mutations (changes) in the EGFR gene. The study will assess the participant demographic background (that is age, gender etc.), the treatments they receive, how well those treatments work, and their health outcomes.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen-Cilag Farmaceutica Ltda.Updated: Aug 28, 2026
Eligibility criteria

Histologically or cytologically confirmed diagnosis of advanced or metastatic un... [+1]

Participants who received any systemic cancer treatment outside the participatin... [+2]

Read more